| Systematic (IUPAC) name | |
|---|---|
| (RS)-1-(4-Fluorophenyl)propan-2-amine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | oral, insufflation |
| Identifiers | |
| CAS number | 459-02-9 |
| ATC code | ? |
| PubChem | CID 9986 |
| ChemSpider | 9592 |
| Chemical data | |
| Formula | C9H12FN |
| Mol. mass | 153.20 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
4-Fluoroamphetamine (4-FA; PAL-303; "Flux",; "Flits", "R2D2"), also known as para-fluoroamphetamine (PFA) is a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes. It produces stimulant and possibly entactogenic effects. 4-FA is a relatively rare drug on the illicit market[citation needed], although it is sometimes sold as a designer drug along with related analogues such as 2-fluoroamphetamine and 4-fluoromethamphetamine, among others.[1][2]
|
Contents
|
The subjective effects of 4-FA include euphoria, increased energy, mood elevation, excessive talking, bruxism (jaw clenching), insomnia and suppressed appetite.
4-Fluoroamphetamine is a potent stimulant and serotonin releaser as with other para-substituted amphetamine derivatives, but is both significantly less potent as a serotonin releaser and much less neurotoxic than related compounds such as parachloroamphetamine.[citation needed]
The dopamine reuptake inhibition produced by 4-FA is stronger than that of either PCA or PIA.[3] 4-FA also produces less hyperthermia than similar compounds such as PMA, 4-MTA and 4-methylamphetamine.
Effects begin within an hour after ingestion. Common dose range is 75-150mg, usually taken orally. The chemical is active insufflated, though this is generally considered unfavorable because of the intense burn the chemical causes.
The serotonin-releasing potency and neurotoxicity[citation needed] of 4-fluoroamphetamine is less than for 4-chloroamphetamine.
Contrary to popular belief, neurotoxicity does not increase down the series of para-halogenated amphetamine derivatives[citation needed], even though serotonin releasing potency does follow this trend. For example, 4-iodoamphetamine is less toxic than is 4-chloroamphetamine.[3][4] Hence, this property is not related to serotonin releasing potency as such, since PAL-287 was reported to be not at all neurotoxic even though it is a powerful 5-HT releasing agent.
Bearing in mind the above statements, it is unclear where 4-methylamphetamine fit in on the neurotoxicity scale. 4-MTA Is an example of a para-substituted, non-neurotoxic amphetamine.[5][6][7]
Regarding the metabolic fate of 4-FA, it is likely excreted from the body entirely unchanged. The C-F bond at the 4-position on the phenyl ring likely resists deactivation in the liver by cytochrome P450 oxidase[8]
|
||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)